Skip to content
Article Rich – Lifestyle
Author:
Treos Bio Corp.
Treos Bio Presents New Translational Data Showing PolyPEPI1018 Plus Anti-PD-L1 Immunotherapy Remodels the Tumor Immune Microenvironment in MSS Colorectal Cancer
July 2, 2026
TREOS Bio Presents New PEPI Technology Data at EACR 2026, Including Six-Year Cancer-Free Outcome in MSS Metastatic Colorectal Cancer (mCRC)
June 9, 2026
TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer
May 28, 2026